↓ Skip to main content

Haloperidol versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs
1 blog
twitter
5 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
187 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Haloperidol versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd003082.pub3
Pubmed ID
Authors

Clive E Adams, Hanna Bergman, Claire B Irving, Stephen Lawrie

Abstract

Haloperidol was developed in the late 1950s for use in the field of anaesthesia. Research subsequently demonstrated effects on hallucinations, delusions, aggressiveness, impulsiveness and states of excitement and led to the introduction of haloperidol as an antipsychotic.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
United Kingdom 1 <1%
India 1 <1%
Portugal 1 <1%
Unknown 182 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 36 19%
Researcher 25 13%
Student > Ph. D. Student 25 13%
Student > Bachelor 24 13%
Other 13 7%
Other 43 23%
Unknown 21 11%
Readers by discipline Count As %
Medicine and Dentistry 72 39%
Psychology 30 16%
Nursing and Health Professions 19 10%
Social Sciences 8 4%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Other 21 11%
Unknown 29 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2017.
All research outputs
#1,006,445
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#3,021
of 8,923 outputs
Outputs of similar age
#20,785
of 239,342 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 107 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,342 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.